HNRNPH3P1

Across TCGA pan-cancer cohorts, HNRNPH3P1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated HNRNPH3P1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher HNRNPH3P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HNRNPH3P1 expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

UCS, ACC, and STAD are the cancer types where HNRNPH3P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.104	0.688	<.001	108	view →
ACC	OS	Tertile	All	0.151	0.835	<.001	72	view →
STAD	DFS	Tertile	All	0.500	0.666	.004	63	view →
MESO	OS	Tertile	All	0.185	0.568	<.001	54	view →
UVM	OS	Tertile	All	0.248	0.769	.007	36	view →
KIRC	DFS	Tertile	IV	0.106	0.640	<.001	36	view →
BLCA	DFS	Tertile	III,IV	0.166	0.477	.003	18	view →
BRCA	DFS	Tertile	II,III,IV	0.651	0.891	.006	18	view →
UCEC	OS	Tertile	IV	0.231	0.592	.036	18	view →
PAAD	DFS	Tertile	All	0.006	0.505	<.001	18	view →
SKCM	OS	Tertile	All	0.518	0.790	.012	9	view →
GBM	DFS	Tertile	All	0.227	0.304	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

HNRNPH3P1–UCS (OS)

Open the UCS breakdown →